CEO: | Phil L'Huillier |
CFO: | Sath Nirmalananthan |
Chief Scientific Officer: | Lindy Durrant |
Deputy Chairman: | Susan Clement Davies |
Non-Executive Chairman: | Jean-Michel Cosséry |
Non-Executive Dir: | Florian Reinaud, Martin Diggle , Ursula Ney |
Address: | Bellhouse Building, Sanders Road, Oxford Science Park, Oxford, United Kingdom , OX4 4GD |
Website: | http://www.scancell.co.uk/ |
Sector: | Pharma and Biotech(LSE) |
Index: | FTSE AIM All-Share |
ISIN: | GB00B63D3314 |
Currency | UK Pounds |
Share Price | 8.75p |
Change Today | -0.25p |
% Change | -2.78 % |
52 Week High | 17.50 |
52 Week Low | 7.50 |
Volume | 4,431,958 |
Shares Issued | 1,037.78m |
Market Cap | £90.81m |
Value | ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
Strong Buy | 1 |
Buy | 2 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 3 |
No dividends found |
Time | Volume / Share Price |
13:29 | 1,750,000 @ 8.62p |
09:39 | 1,000,000 @ 8.10p |
16:07 | 4,507 @ 8.87p |
15:15 | 11,129 @ 8.88p |
14:50 | 25,000 @ 8.88p |
CFO | Sath Nirmalananthan |
CEO | Phil L'Huillier |
You are here: research